About PAIGE
PAIGE is a company based in New York (United States) founded in 2018 by David Klimstra and Thomas Fuchs was acquired by Tempus in August 2025. PAIGE has raised $241 million across 8 funding rounds from investors including Microsoft, Goldman Sachs and Tempus. PAIGE offers products and services including Paige Prostate Suite, Paige Breast Suite, Paige GI Suite, and Paige Alba. PAIGE operates in a competitive market with competitors including PathAI, Viz.ai, Deepcell, Deciphex and Aignostics, among others.
- Headquarter New York, United States
- Founders David Klimstra, Thomas Fuchs
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Paige Ai, Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PAIGE
PAIGE offers a comprehensive portfolio of products and services, including Paige Prostate Suite, Paige Breast Suite, Paige GI Suite, and Paige Alba.
AI for detecting and diagnosing prostate cancer on tissue images
AI applications for breast cancer identification and classification
AI tools for gastrointestinal cancer detection and classification
Multi-modal tool to streamline pathology workflows and diagnostics
People of PAIGE
Unlock access to complete
Unlock access to complete
Funding Insights of PAIGE
PAIGE has successfully raised a total of $241M across 8 strategic funding rounds. The most recent funding activity was a Series C round of $19.5 million completed in January 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in PAIGE
PAIGE has secured backing from 12 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Microsoft, Goldman Sachs and Tempus.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm backed by Johnson & Johnson
|
Locked | Locked | Locked | |
|
Investing in Life Sciences sectors like Healthcare and Biotechnology.
|
Locked | Locked | Locked | |
|
Investment banking services are delivered across multiple financial sectors.
|
Locked | Locked | Locked |
Investor details for PAIGE
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PAIGE
Investment portfolio details for PAIGE
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - PAIGE
Detailed financials for PAIGE
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Paige Comparisons
Peer comparison for PAIGE
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PAIGE
PAIGE operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PathAI, Viz.ai, Deepcell, Deciphex and Aignostics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases
|
|
| Locked | Locked | Locked |
AI and cloud-powered software for stroke care coordination is developed.
|
|
| Locked | Locked | Locked |
AI-powered single cell classification and isolation technology for clinical research
|
|
| Locked | Locked | Locked |
Digital pathology software is developed for clinical and veterinary productivity.
|
|
| Locked | Locked | Locked |
AI-based pathology diagnostic software is provided for medical analysis.
|
|
| Locked | Locked | Locked |
AI-based tools for pathological image analysis are provided to labs.
|
Detailed competitors of PAIGE
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Paige
Complete news archive for PAIGE
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PAIGE
PAIGE was founded in 2018.
PAIGE is headquartered in New York, United States. It is registered at New York, New York, United States.
Razik Yousfi is the current CEO of PAIGE.
PAIGE is a funded company, having raised a total of $241M across 8 funding rounds to date.
Founded in 2018 and based in New York, United States, the company operates in the healthcare technology sector, specializing in AI-driven computational pathology. Deep learning algorithms, utilizing convolutional and recurrent neural networks, are applied to analyze visual and clinical data for cancer diagnosis and treatment. Products such as FullFocus support pathology workflows, while PAIGE.AI aids in patient stratification and biomarker development for treatment planning.
PAIGE's top competitors include Aignostics, Deciphex and Pictor Labs.
PAIGE offers Paige Prostate Suite, Paige Breast Suite, Paige GI Suite, and Paige Alba.
PAIGE has 12 investors. Key investors include Microsoft, Goldman Sachs, Tempus, KKR, and Johnson & Johnson Innovation – JJDC.